Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Metabolomic profiling in small vessel disease identifies multiple associations with disease severity

View ORCID ProfileEric L. Harshfield, Caroline J. Sands, Anil M. Tuladhar, Frank-Erik de Leeuw, Matthew R. Lewis, Hugh S. Markus
doi: https://doi.org/10.1101/2021.05.13.21257190
Eric L. Harshfield
1Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric L. Harshfield
  • For correspondence: eh457{at}medschl.cam.ac.uk
Caroline J. Sands
2National Phenome Centre, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, SW7 2AZ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil M. Tuladhar
3Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Department of Neurology, 6525 AJ Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank-Erik de Leeuw
3Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Department of Neurology, 6525 AJ Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew R. Lewis
2National Phenome Centre, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, SW7 2AZ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugh S. Markus
1Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Cerebral small vessel disease (SVD) is a major cause of vascular cognitive impairment and dementia. There are few treatments, largely reflecting limited understanding of the underlying pathophysiology. Metabolomics can be used to identify novel risk factors in order to better understand pathogenesis and to predict disease progression and severity.

We analysed data from 624 patients with symptomatic cerebral SVD from two prospective cohort studies. Serum samples were collected at baseline and patients underwent MRI scans and cognitive testing at regular intervals with up to 14 years of follow-up. Using ultra-performance liquid chromatography mass spectrometry and nuclear magnetic resonance spectroscopy, we obtained metabolic and lipidomic profiles from 369 annotated metabolites and 54,764 unannotated features and examined their association with respect to disease severity, assessed using MRI SVD markers, cognition, and future risk of all-cause dementia.

Over 100 annotated metabolites were significantly associated with SVD imaging markers, cognition, and progression to dementia. Decreased levels of multiple glycerophospholipids, sphingolipids, and sterol lipids were associated with increased SVD load as evidenced by higher white matter hyperintensities (WMH) volume, lower mean diffusivity normalised peak height (MDNPH), greater brain atrophy, and impaired cognition. Higher levels of several amino acids and nucleotides were associated with higher WMH volume, greater atrophy, and lower MDNPH. Lower baseline levels of carnitines and creatinine were associated with higher annualised change in peak width of skeletonised mean diffusivity (PSMD), and several metabolites, including lower levels of valine, caffeine, and VLDL analytes, were associated with future dementia incidence. Additionally, we identified 1,362 unannotated features associated with lower MDNPH and 2,474 unannotated features associated with increased WMH volume.

Our results show multiple distinct metabolic signatures that are associated with imaging markers of SVD, cognition, and conversion to dementia. Further research should assess causality and the use of metabolomic screening to improve the ability to predict future disease severity and dementia risk in SVD. The metabolomic profiles may also provide novel insights into disease pathogenesis and help identify novel treatment approaches.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by the European Union's Horizon 2020 research and innovation programme under grant agreement No 667375 (CoSTREAM), and the Medical Research Council and National Institute for Health Research (NIHR) (grant MC PC 12025). This research was also supported by the Cambridge University Hospitals NIHR Biomedical Research Centre (BRC-1215-20014) and the NIHR Imperial Biomedical Research Centre. AMT is supported by the Dutch Heart Foundation (Hartstichting) (grant 2016 T044). HSM is supported by a NIHR Senior Investigator Award. Data collection in the SCANS cohort was funded by the Wellcome Trust. The views expressed in this publication are those of the authors and not necessarily those of the NIHR, NHS, or UK Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The SCANS study was approved by the Wandsworth (London) research ethics committee and all patients provided written informed consent. The SCANS study is registered with the UK Clinical Research Network (public.ukcrn.org.uk/; study ID 4577). The RUN-DMC study was approved by the Medical Review Ethics Committee region Arnhem- Nijmegen, and all participants signed an informed consent form.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The raw metabolomics data described in this study were generated at the Medical Research Council National Institute for Health Research (MRC-NIHR) National Phenome Centre. Derived data supporting the findings of this study are available from the corresponding author on request.

  • Abbreviations

    ADL
    Activities of Daily Living
    BI-LISA
    Bruker IVDr Lipoprotein Subclass Analysis
    BI-QUANT
    Bruker IVDr automated quantification of small molecule metabolites
    DTI
    diffusion tensor imaging
    DSM
    Diagnostic and Statistical Manual of Mental Disorders
    FDR
    false discovery rate
    LOESS
    locally estimated scatterplot smoothing
    MDNPH
    mean diffusivity normalised histogram peak height measured within normal appearing white matter voxels
    NMR
    nuclear magnetic resonance
    UPLC-MS
    ultra-performance liquid chromatography mass spectrometry
    PSMD
    peak width of skeletonised mean diffusivity
    RUN-DMC
    Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Imaging Cohort
    SCANS
    St George’s Cognition and Neuroimaging in Stroke
    SD
    standard deviation
    SVD
    small vessel disease
    WMH
    white matter hyperintensities
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
    Back to top
    PreviousNext
    Posted May 14, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Metabolomic profiling in small vessel disease identifies multiple associations with disease severity
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Metabolomic profiling in small vessel disease identifies multiple associations with disease severity
    Eric L. Harshfield, Caroline J. Sands, Anil M. Tuladhar, Frank-Erik de Leeuw, Matthew R. Lewis, Hugh S. Markus
    medRxiv 2021.05.13.21257190; doi: https://doi.org/10.1101/2021.05.13.21257190
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Metabolomic profiling in small vessel disease identifies multiple associations with disease severity
    Eric L. Harshfield, Caroline J. Sands, Anil M. Tuladhar, Frank-Erik de Leeuw, Matthew R. Lewis, Hugh S. Markus
    medRxiv 2021.05.13.21257190; doi: https://doi.org/10.1101/2021.05.13.21257190

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (430)
    • Allergy and Immunology (756)
    • Anesthesia (221)
    • Cardiovascular Medicine (3296)
    • Dentistry and Oral Medicine (364)
    • Dermatology (280)
    • Emergency Medicine (479)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
    • Epidemiology (13381)
    • Forensic Medicine (19)
    • Gastroenterology (899)
    • Genetic and Genomic Medicine (5155)
    • Geriatric Medicine (482)
    • Health Economics (783)
    • Health Informatics (3271)
    • Health Policy (1142)
    • Health Systems and Quality Improvement (1192)
    • Hematology (431)
    • HIV/AIDS (1018)
    • Infectious Diseases (except HIV/AIDS) (14632)
    • Intensive Care and Critical Care Medicine (913)
    • Medical Education (477)
    • Medical Ethics (127)
    • Nephrology (523)
    • Neurology (4928)
    • Nursing (262)
    • Nutrition (730)
    • Obstetrics and Gynecology (883)
    • Occupational and Environmental Health (795)
    • Oncology (2524)
    • Ophthalmology (726)
    • Orthopedics (281)
    • Otolaryngology (347)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (543)
    • Pediatrics (1302)
    • Pharmacology and Therapeutics (551)
    • Primary Care Research (557)
    • Psychiatry and Clinical Psychology (4216)
    • Public and Global Health (7506)
    • Radiology and Imaging (1706)
    • Rehabilitation Medicine and Physical Therapy (1014)
    • Respiratory Medicine (980)
    • Rheumatology (480)
    • Sexual and Reproductive Health (498)
    • Sports Medicine (424)
    • Surgery (548)
    • Toxicology (72)
    • Transplantation (236)
    • Urology (205)